Literature DB >> 21742369

Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma.

Patricia A Convery1, Leigh A Cantrell, Nicola Di Santo, Gloria Broadwater, Susan C Modesitt, Angeles Alvarez Secord, Laura J Havrilesky.   

Abstract

OBJECTIVE: To validate the Mayo algorithm to intraoperatively identify women with endometrial cancer in whom lymphadenectomy may be safely omitted.
METHODS: A multi-center retrospective chart review 1977-2010 was completed using two independent institutional endometrial cancer databases. Eligibility criteria were grade 1 or 2 endometrial carcinoma, low-risk histology, and myometrial invasion ≤ 50% on intraoperative pathology consultation; patients were considered to satisfy the Mayo criteria if, in addition to these, tumor diameter on the final pathology report was ≤ 2 cm. Analysis of nodal metastases, recurrent disease, and progression-free survival (PFS) using the Kaplan-Meier method was performed.
RESULTS: Six hundred and two patients met inclusion criteria for the study. Of 110 patients satisfying the Mayo algorithm with an adequate lymphadenectomy, 2 (1.8%) were diagnosed with lymph node metastasis and 4 (3.6%) subsequently developed recurrent disease. The Mayo algorithm identified with a 98.2% negative predictive value women who would not benefit from a lymphadenectomy. There was no significant difference in recurrence rate or PFS between women who underwent lymphadenectomy and those who did not when the Mayo algorithm was satisfied.
CONCLUSIONS: The Mayo algorithm intraoperatively identifies tumor characteristics of low-risk disease in endometrial carcinoma that predict a very low likelihood of nodal metastasis and recurrence. Although a small number of patients with advanced stage disease may be missed when applying the Mayo criteria, there is no apparent survival benefit to lymphadenectomy for patients satisfying this algorithm, and these data support its use at other institutions.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21742369     DOI: 10.1016/j.ygyno.2011.06.025

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  21 in total

1.  Nodal metastasis risk in endometrioid endometrial cancer.

Authors:  Michael R Milam; James Java; Joan L Walker; Daniel S Metzinger; Lynn P Parker; Robert L Coleman
Journal:  Obstet Gynecol       Date:  2012-02       Impact factor: 7.661

2.  Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer.

Authors:  Sanjeev Kumar; Karl C Podratz; Jamie N Bakkum-Gamez; Sean C Dowdy; Amy L Weaver; Michaela E McGree; William A Cliby; Gary L Keeney; Gillian Thomas; Andrea Mariani
Journal:  Gynecol Oncol       Date:  2013-10-09       Impact factor: 5.482

3.  Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer.

Authors:  Priya Bhosale; Jingfei Ma; Revathy Iyer; Preetha Ramalingam; Wei Wei; Pamela Soliman; Michael Frumovitz; Vikas Kundra
Journal:  J Magn Reson Imaging       Date:  2015-07-16       Impact factor: 4.813

4.  Clinically significant endometrial cancer risk following a diagnosis of complex atypical hyperplasia.

Authors:  Anthony B Costales; Kathleen M Schmeler; Russell Broaddus; Pamela T Soliman; Shannon N Westin; Pedro T Ramirez; Michael Frumovitz
Journal:  Gynecol Oncol       Date:  2014-10-12       Impact factor: 5.482

5.  Comparative effectiveness research in gynecologic oncology.

Authors:  Sonali Patankar; Ana I Tergas; Jason D Wright
Journal:  Cancer Treat Res       Date:  2015

6.  The Advantage of Pinpoint Camera System With Indocyanine Green for Sentinel Lymph Node Micrometastasis Detection in Low Risk Endometrial Cancer.

Authors:  Alexandros Lazaridis; Stylianos Kogeorgos; Panagiotis Balinakos; Kitty Pavlakis; Theofani Gavresea; George Pistofidis
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

7.  Stratification of endometrioid endometrial cancer patients into risk levels using somatic mutations.

Authors:  Donghai Dai; Kristina W Thiel; Erin A Salinas; Michael J Goodheart; Kimberly K Leslie; Jesus Gonzalez Bosquet
Journal:  Gynecol Oncol       Date:  2016-05-16       Impact factor: 5.482

8.  Assessment of the Intraoperative Consultation Service Rendered by General Pathologists in a Scenario Where a Well-Defined Decision Algorithm Is Followed.

Authors:  Mahmoud A Khalifa; Sherine Salama; Rachel I Vogel; Molly E Klein; James Richter; Tanya Pulver; Sally A Mullany; Boris Winterhoff
Journal:  Am J Clin Pathol       Date:  2017-03-01       Impact factor: 2.493

9.  Development and validation of predictive model for lymph node metastasis in endometrial cancer: a SEER analysis.

Authors:  Xingchen Li; Yuan Cheng; Yangyang Dong; Jingyi Zhou; Zhiqi Wang; Xiaoping Li; Jianliu Wang
Journal:  Ann Transl Med       Date:  2021-04

10.  Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma.

Authors:  Agnes Y Bahng; Christina Chu; Paul Wileyto; Stephen Rubin; Lilie L Lin
Journal:  J Gynecol Oncol       Date:  2012-09-19       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.